Baxter Market Cap 2006-2018 | BAX

Interactive chart of historical market capitalization for Baxter (BAX) over the last 10 years. The current market cap for Baxter as of August 17, 2018 is $38.49B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $38.489B $10.561B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $122.465B 18.95
Abbott Laboratories (ABT) United States $113.540B 23.79
Stryker (SYK) United States $63.571B 24.56
Boston Scientific (BSX) United States $47.586B 24.75
Zimmer Biomet Holdings (ZBH) United States $25.204B 16.19
Smith & Nephew SNATS (SNN) United Kingdom $15.640B 0.00
ResMed (RMD) United States $15.244B 30.25
Perrigo (PRGO) Ireland $9.983B 14.17
Bio-Rad Laboratories (BIO) United States $9.444B 60.64
Canopy Growth (CGC) Canada $7.445B 0.00
Hill-Rom Holdings (HRC) United States $6.341B 21.51
ICU Medical (ICUI) United States $6.026B 40.83
Haemonetics (HAE) United States $5.351B 48.83
Insulet (PODD) United States $5.209B 0.00
Agios Pharmaceuticals (AGIO) United States $4.408B 0.00
Neogen (NEOG) United States $4.360B 69.38
Hutchison China MediTech (HCM) China $3.903B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.778B 0.00
NuVasive (NUVA) United States $3.598B 34.13
National Vision Holdings (EYE) United States $3.054B 67.43
Quidel (QDEL) United States $2.769B 56.74
Phibro Animal Health (PAHC) United States $1.990B 29.55
NxStage Medical (NXTM) United States $1.846B 0.00
Cardiovascular Systems (CSII) United States $1.249B 751.20
Eagle Pharmaceuticals (EGRX) United States $1.176B 34.73
VAREX IMAGING (VREX) United States $1.130B 18.47
AtriCure (ATRC) United States $1.099B 0.00
Omeros (OMER) United States $1.016B 0.00
OraSure Technologies (OSUR) United States $1.001B 65.44
Owens & Minor (OMI) United States $0.990B 10.59
Surmodics (SRDX) United States $0.981B 118.47
TG Therapeutics (TGTX) United States $0.957B 0.00
Cerus (CERS) United States $0.922B 0.00
PetIQ (PETQ) United States $0.847B 29.00
MacroGenics (MGNX) United States $0.845B 0.00
LeMaitre Vascular (LMAT) United States $0.716B 34.34
Meridian Bioscience (VIVO) United States $0.632B 21.59
Insys Therapeutics (INSY) United States $0.574B 0.00
Evolus (EOLS) United States $0.527B 0.00
Lantheus Holdings (LNTH) United States $0.515B 16.01
NanoString Technologies (NSTG) United States $0.417B 0.00
Cytosorbents (CTSO) United States $0.363B 0.00
BioLife Solutions (BLFS) United States $0.325B 0.00
Utah Medical Products (UTMD) United States $0.324B 20.86
Quanterix (QTRX) United States $0.324B 0.00
Surface Oncology (SURF) United States $0.279B 0.00
Rockwell Medical (RMTI) United States $0.216B 0.00
Chimerix (CMRX) United States $0.195B 0.00
Fonar (FONR) United States $0.170B 10.34
Chembio Diagnostics (CEMI) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.119B 0.00
Female Health (VERU) United States $0.115B 0.00
United-Guardian (UG) United States $0.086B 18.83
Trinity Biotech (TRIB) Ireland $0.085B 25.25
Oramed Pharmaceuticals (ORMP) Israel $0.082B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.064B 0.00
CAS Medical Systems (CASM) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Capricor Therapeutics (CAPR) United States $0.032B 0.00
Akers Biosciences Inc (AKER) United States $0.025B 0.00
Senestech (SNES) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00